Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Medical Imaging (Mammography, Breast Cancer) Companies
Lumicell Diagnostics

Organization & Developments: Lumicell

Parents

2020: Lumicell Announces Initiation of NIH/NCI Academic-Industry Study of its LUM Imaging System_prweb17423360
2020: Lumicell Granted Fast Track Designation Approval by the FDA for Breast Cancer Treatment_Press Releases
Additional future indications are planned to include perfusion, wound care and infection, and surgeries for lung, and liver cancers
Developer of a device enabling doctors to check tumor sites for remaining cancer cells after surgeries
Industry: Medical Devices & Equipment Sub-Industry: Imaging & Diagnostic Equipment
Lumicell Diagnostics is developing a device that will enable surgeons to check the tumor site immediately following surgery for remaining cancer cells after removing the tumor.
Lumicell is a technology leader in the field of image-guided cancer surgery.
Lumicell is investigating the LUM Imaging System in patients undergoing surgery for breast cancer, ovarian cancer, prostate cancer, brain cancer, colorectal, esophageal and pancreatic cancers.
The company is developing a novel system that enables real-time detection of tumor tissue in patients so that no cancer cells are left behind during surgery.
The company’s LUM Imaging System has unprecedented ability to see and guide removal of cancer cells remaining in the surgical cavity – beyond the margin of the specimen – and has the potential to significantly improve surgical outcomes and reduce healthcare costs by eliminating the need for repeat surgeries.